CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)
Phase 1 · 5 sites
Search the registry
2,585 studies found
Phase 1 · 5 sites
Phase 1 / Phase 2 · 1 site
Phase 2 · 80 sites
Phase 1 / Phase 2 · 1 site
Phase 1 / Phase 2 · 21 sites
Potential match only. Final eligibility is determined by the study team.